Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
View Patent ↗The use of resveratrol is described fir the preparation of a medicament for the treatment of influenza. Said medicament exerts itself in therapeutic activity through inhibition of viral replication.
1. A method of inhibiting influenza virus replication comprising administering to a subject having an influenza virus infection an amount of resveratrol which inhibits influenza virus replication and does not inhibit influenza virus target cell entry.
2. The method of claim 1 wherein the subject is a human and the influenza virus is human influenza virus.
3. The method of claim 1 wherein the influenza infection is a veterinary virus infection and the subject is a veterinary animal.
4. A method of treating an influenza virus infection comprising administering to a subject having an influenza infection an effective amount of resveratrol, which inhibits influenza virus replication and does not inhibit influenza virus target cell entry.
5. The method of claim 4 wherein the subject is a human and the influenza virus is human influenza virus.
6. The method of claim 4 wherein the influenza infection is a veterinary virus infection and the subject is a veterinary animal.
7. A method of non-reversibly inhibiting influenza virus replication comprising administering to a subject having an influenza infection an amount of resveratrol which inhibits influenza virus replication and does not inhibit influenza virus target cell entry.
8. The method of claim 7 wherein the subject is a human and the influenza virus is human influenza virus.
9. The method of claim 7 wherein the influenza infection is a veterinary virus infection and the subject is a veterinary animal.
10. A method of treating an influenza virus infection comprising administering to a subject having an influenza infection an effective amount of resveratrol which non-reversibly inhibits influenza virus replication and does not inhibit influenza virus target cell entry.
11. The method of claim 10 wherein the subject is a human and the influenza virus is human influenza virus.
12. The method of claim 10 wherein the influenza infection is a veterinary virus infection and the subject is a veterinary animal.